About this trial
The LATAM Bif Registy is an international and prospective registry of percutaneous coronary interventions (PCI) in coronary bifurcation lesions. The main goal of the study is to investigate the current state and long-term outcomes of PCI in this complex subset of coronary lesions in Latin America.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age >= 18 years
Any type of bifurcation lesion
Side-branch reference diameter >= 2 mm
Disqualifiers
Protected left main disease in patients with previous CABG
Patients who refuse to be included in the registry
Trial population
All patients ≥18 years of age, who have at least one significant lesion in a coronary bifurcation on diagnostic cinecoronary angiography and who are candidates to treatment with PCI, regardless of the dedicated-technique used. Those patients who present lesions involving vessels \<2 mm by visual estimation and those who refuse to be included in the registry will be excluded.
Trial design
Cohort
Prospective
Treatments tested in this trial
Percutaneous coronary interventions
Procedure/SurgeryPercutaneous coronary interventions in coronary bifurcation lesions
Treatment groups
Trial outcomes
Primary outcomes
Cardiac Death
Myocardial Infarction
Target Lesion Revascularization
Stent thrombosis
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: